EntryPoint Capital’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
EntryPoint Capital's EIKN Position: Q3 2026 in Review
EntryPoint Capital opened a new position in Eikon Therapeutics (EIKN) in Q3 2026: 47,943 shares worth $385K. The stake represents 0.11% of the portfolio and ranks #374 among its holdings.
98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.
- EntryPoint Capital held 47,943 shares of Eikon Therapeutics worth $385K as of Q3 2026.
- Eikon Therapeutics was a new EntryPoint Capital position in Q3 2026.
- Eikon Therapeutics made up 0.11% of EntryPoint Capital's portfolio in Q3 2026, its #374 holding.
- 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.
Based on EntryPoint Capital's 13F filing for Q3 2026, filed 13 Nov 2026.